about
Mice with targeted disruption of p8 gene show increased sensitivity to lipopolysaccharide and DNA microarray analysis of livers reveals an aberrant gene expression responseKIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisTransforming growth factor beta-1 enhances Smad transcriptional activity through activation of p8 gene expressionStructural and functional characterization of the mouse p8 gene: promotion of transcription by the CAAT-enhancer binding protein alpha (C/EBPalpha) and C/EBPbeta trans-acting factors involves a C/EBP cis-acting element and other regions of the promoA genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studiesRecent advances in the understanding of mastocytosis: the role of KIT mutations.Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcomeEx vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow.Current state of biology and diagnosis of clonal mast cell diseases in adults.Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis.Cell purification: a new challenge for biobanks.Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis.Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression.A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk.Expression of the stress-induced p8 mRNA is transiently activated after culture medium change.A new simple whole blood flow cytometry-based method for simultaneous identification of activated cells and quantitative evaluation of cytokines released during activation.A new method for detecting TNF-alpha-secreting cells using direct-immunofluorescence surface membrane stainings.The pancreatitis-associated protein induces lung inflammation in the rat through activation of TNFalpha expression in hepatocytes.Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis.A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis.Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study.CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.Implementation of a cost-accounting model in a biobank: practical implications.An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.Evaluation of the WHO criteria for the classification of patients with mastocytosis.Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens.Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis.Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.
P50
Q24802943-E3A7BFE3-94D6-4AE0-B307-518A5AD03FE7Q26830207-3EAF55D1-4421-4188-A06B-6C88B34799CFQ28367243-E53F7731-AB78-4B81-8FD1-EC0693CCDFC2Q28505515-C8752BF9-1D36-45E5-B690-F0A59BA2BA77Q28943442-F22DAB25-DC26-4CE8-88C0-9F17B5F7AAF0Q33158687-163B2D0F-078B-4E28-ABC2-4F6175486DC4Q33683171-237DFBE9-5872-4837-8BE3-9FCD25EBFE00Q34635424-B34BE0CC-CE16-4F0F-B9D4-A80D886F93ADQ34987900-17B5238B-1960-47CE-A714-A4CB10F83644Q35025246-27B666FA-26CF-4FCD-AD81-DEFD4239CDBEQ36034814-672224C7-2863-46FA-B701-19AF88BEF5C1Q38007005-9E5F22A5-2150-45A6-86CB-D275E2F7A2C3Q38205501-B30CBC8E-2101-4531-AC05-E81716525038Q38266219-C22384AF-FF5F-4506-BC02-9722F4C79770Q38384676-95E61FE4-A489-4BB6-8704-6CF1B4AD85A0Q38905860-C3A1229B-086B-4EB5-8990-F9ADEE728889Q40992479-78153D3D-9E6A-49D3-9925-FB7A6A6D43FCQ41604021-33226B04-D938-47BB-BC83-44D12E05BCA5Q41728348-4DD2FDE2-D8A8-4491-B446-BE697D16D3DFQ42819002-BF30017C-83C4-4CCA-8315-47BCF370CFB5Q44020998-6B71548A-5DF5-4A21-9383-15CBBAB41FD4Q44111159-B6780103-7AD7-4D35-BCE3-CAB4E35FF8A9Q44310410-730505D1-1B4E-4DED-9396-1C5D8A158FD7Q44767953-0047D7D5-CB64-483D-93AA-AE452B7A0033Q44959863-683931E4-142B-4A88-A6CA-7BDED718F861Q46180609-53133D0A-7338-40CC-93C5-3314C54D4348Q48013095-2E906E25-A5BB-4BB5-8434-1AE841809D2EQ48253201-99416669-109C-45B7-8864-8290424C6B16Q50454051-29A888EC-C14B-4115-9107-A6023AC5CB0AQ50484927-479B218E-1F2B-42BB-8A95-484E5101124DQ50900052-E863D677-C7EF-458B-9754-239D730EAAF3Q51013817-7D897559-534A-4310-BE28-A92BC7DEA551Q51129802-699D15DE-969C-4C64-8E5D-12FB6FBAFFC5Q51505022-87DA4A14-F555-4A7F-986F-0C65CF9156E1Q51571187-AD71ACBD-B14B-4AEA-80C4-40B2B313BAA2Q51962180-852946C6-1794-46E2-854C-DA49214D0777Q52687592-E7F5076F-69AA-46C7-9B83-BB7731846327Q52750513-E58D2BBA-CE7A-4A6C-8774-15164A6D1CF3Q52884801-80D7CCD6-2B1B-4137-9746-92D3E7EF8124Q53093872-9AE5128E-E6EE-4EA9-9DE1-54E847C8BC34
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrés García-Montero
@ast
Andrés García-Montero
@en
Andrés García-Montero
@es
Andrés García-Montero
@nl
Andrés García-Montero
@sl
type
label
Andrés García-Montero
@ast
Andrés García-Montero
@en
Andrés García-Montero
@es
Andrés García-Montero
@nl
Andrés García-Montero
@sl
altLabel
garcia montero a*
@en
prefLabel
Andrés García-Montero
@ast
Andrés García-Montero
@en
Andrés García-Montero
@es
Andrés García-Montero
@nl
Andrés García-Montero
@sl
P1053
B-6558-2017
P106
P21
P31
P3829
P496
0000-0003-4360-1386